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An analysis of findings regarding the prevalence and time course of symptoms and the results of
neurobehavioral testing among Michigan and Wisconsin dairy farnmrs, is reported. Reviewed are: (1)
differences in the prevalence of neurological symptoms at the time of examination; (2) differences in the
incidence and time course ofsymptoms for the period 1972-1976; (3) differences among populations and
subgroups (sex and age) regarding performance test scores; (4) correlations between performance test
scores and neurological symptoms; and (5) correlations between serum PBB levels as indicators of expo-
sure and performance tests and neurological symptoms.
This is a report offindings regarding performance
test scores and neurological symptoms in individu-
als suspected of being exposed to polybrominated
biphenyls (PBB) in Michigan (primarily dairy farm
residents) and within a control population of dairy
farm residents in Wisconsin. Reviews of PBB tox-
icity and of the Michigan PBB incident have been
published elsewhere (1-5). The present study was
part of comprehensive medical field survey con-
ducted by our Laboratory between November 1976
and March 1977 in Michigan and Wisconsin.
The major questions addressed in this report in-
clude: (1) the prevalence of neurological symptoms
in the Michigan population exposed to PBB and its
difference from that in the Wisconsin, non-PBB ex-
posed group; (2) differences in the incidence and
time course of symptoms in the Michigan and Wis-
consin populations for the period 1972-1976; (3)
differences in standard performance test scores; (4)
correlation between prevalence of symptoms (if
found) with the results of objective performance
test aimed at assessing neuropsychological dys-
function; (5) contributions of sex, age, and educa-
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tion to the prevalence of neurological symptoms
and/or the performance test scores; (6) correlations
of performance test results with serum PBB levels;
and (7) correlations between specific neurological
symptoms and serum PBB levels.
Materials and Methods
Subjects
The symptoms of 644 adults from Michigan and
153 from Wisconsin were analyzed for prevalence
and incidence of neuropsychological symptomatol-
ogy. The characteristics of these two populations
and patterns of symptoms other than neurological
are discussed elsewhere in this issue (6).
The subsample examined by means of perfor-
mance tests were 102 males and 68 females from
Michigan and 50 males and 43 females from Wis-
consin. The subsample was chosen at random dur-
ing comprehensive crosssectional clinical surveys
in these two states. All examinees were whites. The
educational level ranged from a few years of
schooling to individuals with college degrees. The
distribution ofeducational levels in the two popula-
tions is almost identical with a peak at a unit be-
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degree or a little higher. The peaks of the age dis-
tribution for Michigan and Wisconsin were located
at 35-44 and 45-54 years of age. The weight attrib-
uted to educational level and age in these tests has
been discussed elsewhere (7). Other factors being
equal, the average scores of the Wisconsin sample
are expected to be lower than the Michigan sample
because of these differences (not statistically sig-
nificant) in age. In a few cases and for a variety of
reasons (such an interruption ofthe testing for com-
pelling reasons or physical handicap) data for indi-
vidual tests in some are missing.
Neurobehavioral Tests
Block Design (BD), Digit Symbol (DS), and Em-
bedded Figures (EF) tests were used in the assess-
ment of performance of the populations studied.
The Block Design test is widely used in the evalua-
tion of the effects of neurotoxic substances. The
test provides a quick and objective measure of the
subject's ability to visualize spatial relations. The
examinee is presented with a set of colored cubes.
Each cube has sides which are red, white, and half
red and half white. The task requires arranging the
cubes so that the top surface reproduces a displayed
design. In the first six trials, only four of the cubes
are used and the designs to be reproduced are rela-
tively simple. In the last four trials, nine cubes are
used and the designs are more complex. The score
is based on the number ofcorrectly completed trials
as well as the speed with which the test is ac-
complished.
The Digit Symbol test assesses the subject's abil-
ity to associate symbols according to a code. The
subject is given a list in which symbols are as-
sociated with digits from 1 to 9 and is asked to enter
the symbols into the blank spaces next to a list of
random digits on a form. The score is the number of
symbols correctly entered in 90 sec.
The Embedded Figures test has been extensively
used in neurological research, particularly during
World War II. The test, consisting of four sets of
superimposed outlines ofcommon objects, assesses
visual perception in masked conditions. The score
is the total number ofobjects successfully identified
in the four sets.
Reliability and Validity of Tests
Test-retest reliability data for the Block Design
test and for the Digit Symbol test have been pro-
vided by Wechsler (8). The test-retest correlation
coefficient is between 0.82 and 0.85 for ages 18-54
and 0.80 for ages 16-24 respectively. The Embed-
ded Figures test has been developed in our labora-
tory in studies ofover600 subjects classified by age,
sex, race, education, occupation, geographic area,
rural or urban living and native language (English
and Spanish). This battery of tests has been shown
to be sensitive in detecting subclinical central ner-
vous system dysfunction as a result of excessive
exposure to lead (7).
All test scores correlated positively and signif-
icantly among themselves within the control and
test population. Age correlated significantly and
negatively with all behavioral test scores in both
groups. Matrices of test intercorrelations are given
in Tables 1 and 2.
Table la. Matrices of intercorrelations between age, education,
and performance test scores (males, three age groups, Wisconsin).
Age, Correlations
yr N Age Educ. BD DS EF DDE PPB
0-29 16 Age +1.00-0.08 +0.24-0.09 +0.12
Educ. +1.00-0.23 +0.49 +0.68
BD +1.00-0.37 +0.20
DS +1.00 +0.36
EF +1.00
DDE +1.00
PBB +1.00
30-49 14 Age + 1.00-0.39 -0.07 -0.39 -0.29
Educ. + 1.00 +0.24 +0.56 +0.17
BD + 1.00 +0.53 +0.41
DS +1.00+0.15
EF +1.00
DDE +1.00
PBB +1.00
50 22 Age +1.00-0.19-0.41 -0.49-0.63
Educ. + 1.00 +0.28 +0.49-0.12
BD + 1.00 +0.60 +0.57
DS +1.00 +0.46
EF +1.00
DDE +1.00
PBB +1.00
Table lb. Matrices ofintercorrelation between age, education, and
performance test scores (females, three age groups, Wisconsin).
Age, Correlations
yr N Age Educ. BD DS EF DDE PBB
0-29 7 Age + 1.00 +0.62-0.50 -0.58 -0.69
Educ. + 1.00-0.71 -0.47 +0.37
BD + 1.00 +0.10 +0.22
DS +1.00 +0.26
EF + 1.00
DDE +1.00
PBB + 1.00
30-49 18 Age + 1.00-0.12 -0.18 -0.45 -0.15
Educ. + 1.00 +0.08 -0.23 -0.08
BD +1.00+0.12+0.31
DS + 1.00 +0.27
EF +1.00
DDE +1.00
PBB +1.00
50 16 Age +1.00-0.15-0.61 -0.44-0.38
Educ. + 1.00 +0.28 +0.56 +0.48
BD + 1.00 +0.25 +0.63
DS + 1.00 +0.22
EF + 1.00
DDE + 1.00
PBB +1.00
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(males, three age groups, Michigan).
Correlations
Age, yr N r (0.05) r (0.01) Age Educ. BD DS EF DDE PBB
0-29 23 0.39 0.50 Age +1.00 +0.35 -0.02 -0.16 -0.12 +0.08 +0.27
Educ. +1.00 +0.35 +0.12 +0.15 -0.12 -0.02
BD + 1.00 +0.42 +0.49 +0.02 +0.18
DS + 1.00 +0.50 -0.35 +0.23
EF +1.00 -0.07 +0.13
DDE + 1.00 +0.32
PBB + 1.00
30-49 46 0.29 0.37 Age +1.00 -0.41 -0.20 -0.43 -0.22 +0.21 -0.20
Educ. +1.00 +0.34 +0.54 +0.31 -0.20 -0.02
BD + 1.00 +0.42 +0.60 +0.02 -0.06
DS + 1.00 +0.30 -0.05 -0.01
EF + 1.00 +0.08 -0.06
DDE + 1.00 -0.05
PBB +1.00
a 50 15 0.48 0.60 Age +1.00 +0.40 -0.34 -0.45 -0.51 +0.57 +0.69
Educ. + 1.00 +0.17 +0.10 -0.12 +0.66 +0.64
BD + 1.00 +0.28 +0.69 -0.30 -0.32
DS +1.00 +0.51 -0.41 -0.41
EF + 1.00 -0.59 -0.47
DDE + 1.00 +0.94
PBB +1.00
Table 2b. Matrices of intercorrelations between age, education, performance test scores, and serum DDE and PBB
(females, three age groups, Michigan).
Correlations
Age, yr N r (0.05) r (0.01) Age Educ. BD DS EF DDE PBB
0-29 19 0.43 0.55 Age +1.00 +0.05 +0.15 -0.14 -0.18 +0.43 +0.19
Educ. + 1.00 +0.35 +0.48 +0.09 -0.32 -0.43
BD +1.00 +1.07 +0.53 +0.16 +0.05
DS + 1.00 -0.00 -0.20 +0.05
EF +1.00 -0.21 +0.14
DDE + 1.00 +0.34
PBB +1.00
30-49 27 0.36 0.47 Age +1.00 +0.35 -0.14 -0.42 -0.13 +0.47 +0.37
Educ. +1.00 +0.01 +0.40 +0.09 +0.07 -0.16
BD + 1.00 +0.26 +0.38 +0.02 +0.03
DS + 1.00 +0.32 -0.06 -0.23
EF +1.00 -0.15 -0.16
DDE +1.00 +0.60
PBB +1.00
¢ 50 11 0.55 0.68 Age +1.00 -0.11 +0.17 -0.34 -0.18 +0.29 -0.36
Educ. +1.00 +0.47 +0.42 +0.56 -0.31 +0.17
BD +1.00 +0.02 +0.35 -0.14 +0.41
DS +1.00 -0.13 -0.04 -0.09
EF +1.00 +0.29 -0.15
DDE +1.00 -0.21
PBB +1.00
Symptoms
Table 3 gives a list ofall symptoms recorded on a
special questionnaire used in the examination ofthe
Michigan and Wisconsin populations. The ques-
tionnaires were administered by physicians; the
presence or absence-and, if present, the inten-
sity-ofeach symptom were recorded forthe period
preceding the year 1973, and for each consecutive
year including 1976.
Biological Indicators of Exposure
PBB in blood serum was analyzed according to
the procedure of Liddle, Price, and Bayse (9).
Since serum 1,1-dichloro-2,2-bis (p-chlorophenyl)-
ethylene (DDE) was readily obtained in these
analyses, it has been reported, in addition to PBB.
DDE residues in humans are derived from accumu-
lated environmental exposures to DDT and DDE,
the latter occurring as a biological dehydrochlori-
April 1978 201Table 3. List of all questions of the Special Questionnaire used to
study the comparative prevalence of symptoms in Michigan and
Wisconsin for the period 1972-1976.
Eye initation
Nasal iritation
Sore throat
Cough
Wheenng
Tightness in chest
Skdn rash
Acne
Senstivity to sun
Burning sensation on skin
Darkening ofsidn
Thickening ofsidn
Discoloration or deformation
offingernails
Slower or poorer healing ofcuts
Lost more than 10 lb without dieting
Appetite lost
Nausea
Abdominal pain
Pain related to meals
Crampy abdominal pain
Constipation
Diarrhea
Red unne
Brown urine
Headaches
Blurred vision
Dizziness
Depression
Tiredness
Perceptual changes
Nervousness
Sleeplessness
Sleepiness
Muscle weakness
Difficulty in walkng
Paresthesia
Loss ofbalance
Joint pain
Swelling ofjoints
Pain in lower back and legs
Dry sldn
Thyroid
Change ofvoice
Increased perspiration
nation product ofDDT. Serum obtained from blood
in Vacutainers was transferred to glass vials, with
Teflon-lined caps, previously washed and rinsed
successively with detergent and water, distilled
water, acetone and hexane, and frozen until
analyzed.
Briefly, a hexane-ether extract (3 x 5 ml) of
methanol (2 ml)-treated serum (4 ml) was eluted
through a Florisil (1.6 g) column topped with
sodium sulfate. The first 13 ml hexane eluate was
analyzed by electron-capture gas chromatography
(63Ni detector) on a 3 ft x 1/4 in. 1% OV101 on 80/100
Supercoport glass column at 240TC. Retention times
were approximately 8 min for hexabromobiphenyl,
20 min for heptabromobiphenyl, and 1.5 min for
DDE. Recoveries ofPBB from serum and standard
solutions (hexane) and from serum (spiked with
PBB in DMSO) of PBB were 97 + 12% and 94 +
11% (mean + standard deviation) respectively.
Analysis for PBB was based on the major peak,
2,4,5-2',4',5'-hexabromobiphenyl.
Serum extracts were diluted to less than 500
ng/ml, which was well within the range of linearity
of the detector for PBB. The limit of detectability
(less than 1000 integrator area units) was ca. 5 pg
total injection, and quantitative recovery of PBB
from spiked serum samples was successful at 0.2
ppb.
Additional information on the results of PBB de-
terminations in serum for these populations are re-
ported herein (10, 11).
Variables Considered in the
Analysis of Data
The population examined (Michigan) was
grouped according to whether the individuals re-
sided on quarantined or nonquarantined farms or
were consumers of products purchased from such
farms or workers employed by Michigan Chemical
Corporation, manufacturers of the PBB. The
descriptionofthesegroups hasbeenreported (6)and
a description of behavioral differences in these
groups has been discussed (12).
Other variables considered in the analysis of
neurobehavioral data were: sex, race, age, educa-
tion, results of behavioral test described above,
PBB and DDE in serum, and symptoms before 1973
and in the period 1973-1976 as described above.
Statistical Analysis of Data
Correlation coefficients, computed among all
variables, are presented as intercorrelation matrices
for both Michigan and Wisconsin residents (Tables
1 and 2). Correlation coefficients were obtained for
an equal number ofcases within the Michigan group
(173) and the Wisconsin group (93). t-tests for inde-
pendent samples were computed to assess male vs.
female and male vs. male and female vs. female
differences (Tables 4 and 5).
Results
Performance Tests
Figure 1 depicts the mean of scores for three
performance tests (BD, DS, and EF) in males (black
bars) and females (white bars) in Michigan and Wis-
consin for three age groups (0-29, 30-49, and > 50).
Serum PBB and DDE levels mean values are also
indicated. Statistical differences between males and
females at the five and one percent level of signifi-
cance are indicated by one and two asterisks, re-
spectively. Table 4 contains numerical data corre-
sponding to this illustration.
It was found that females scored better than
males in the DS test both in Michigan and Wiscon-
sin in the three age groups. However, for the Michi-
gan subgroup of age 50 and over, males scored
worse than females in two additional tests (BD and
EF). Serum PBB level differences between males
and females are highly significant in all three age
groups in Michigan (Table 5).
Table6 shows the correlation between age, serum
PBB, DDE levels, and performance test scores for
males and females from Michigan. Analysis of
Environmental Health Perspectives 202Table 4. Results of performance tests (BD, DS, and EF) and mean PBB and DDE levels for males and females
from Michigan and Wisconsin in three age groups.a
Wisconsin Michigan
Malesa Femalesb Malesc Femalesd
Age, yr Mean SD Mean SD t p Mean SD Mean SD t p
0-29 Age 19.1 3.01 2.05 4.83 -0.85 NS 23.3 3.26 22.1 3.81 +.99 NS
Educ. 2.87 0.93 3.3 0.85 -0.19 NS 3.33 0.66 3.26 0.93 +.25 NS
BD 29.7 7.5 28.8 5.84 +0.28 NS 30.3 9.7 29.3 7.50 +.34 NS
DS 54.4 14.9 61.6 7.91 -1.19 NS 50.6 10.4 58.9 6.89 -2.83 <0.005
EF 34.2 4.3 33.6 4.35 -0.30 NS 34.1 4.4 34.3 4.58 -1.29 NS
DDE 11.6 8.4 7.67 4.0 +1.81 <0.05
PBB 60.2 195.6 2.5 2.54 + 1.28 NS
30-49 Age 41.9 5.34 38.9 5.16 +1.60 =-0.05 38.91 5.78 38.4 5.74 -0.35 NS
Educ. 2.94 1.26 3.2 0.61 -0.74 NS 3.01 0.99 2.94 0.81 +0.31 NS
BD 27.9 9.2 26.9 9.22 +0.30 NS 28.8 8.6 24.8 9.68 + 1.83 <0.05
DS 45.3 10.9 57.0 11.26 -2.95 <0.005 42.2 14.2 56.6 12.46 -4.37 <0.005
EF 33.6 3.7 32.8 4.55 +0.53 NS 31.4 5.2 33.9 3.08 -2.27 <0.025
DDE 17.7 10.8 13.8 8.04 + 1.62 <0.05
PBB 37.8 195.0 3.26 6.78 +0.92 NS
¢ 50 Age 58.1 6.10 54.7 10.5 +1.15 NS 57.4 6.27 54.0 2.65 +1.63 <0.05
Educ. 2.38 .83 2.97 1.06 -1.70 <0.05 2.86 0.91 3.13 0.78 -0.79 NS
BD 20.9 10.3 23.9 9.19 -0.78 NS 19.7 6.56 26.9 7.48 -2.61 <0.005
DS 34.0 10.5 50.0 11.02 -3.93 <0.005 30.5 7.81 48.18 10.51 -4.93 <0.005
EF 27.7 7.7 31.7 4.34 -1.52 =0.05 24.9 8.15 31.5 5.13 -2.35 <0.025
DDE 26.6 28.1 17.9 5.11 +1.00 NS
PBB 27.4 456.7 2.93 1.99 +7.31 > 0.001
a For 0-29 yr, N = 16; 30-49, N =14; 50, N 22.
b For 0-29 yr, N = 7; 30-49, N = 18;
¢
50, N = 16.
For 0-29 yr, N = 16; 30-49, N = 46; > 50, N = 15.
'For 0-29 yr, N = 19; 30-49, N 27; ¢ 50, N 1.
Table 5. Michigan vs. Wisconsin, performance tests and PBB and DDE levels, t-tests, male vs. male
and female vs. female for three age groups.
Males Females
Wisconsina Michiganb Wisconsinc Michigand
Age, yr Mean SD Mean SD t p Mean SD Mean SD t p
0-29 Age 19.1 3.01 23.3 3.26 -4.08 <0.01
Educ. 2.87 0.93 3.33 0.66 - 1.81 NS
BD 29.7 7.5 30.3 9.7 -0.21 NS
DS 54.4 14.9 50.6 10.4 -0.94 NS
EF 34.2 4.3 34.1 4.4 -0.07 NS
DDE 11.6 8.4
PBB 60.2 195.6
30-49 Age 41.9 5.34 38.91 5.78 + 1.72 <.05
Educ. 2.94 1.26 3.01 0.99 -0.22 NS
BD 27.9 9.2 28.8 8.6 -0.33 NS
DS 45.3 10.9 42.2 14.2 +0.75 NS
EF 33.6 3.7 31.4 5.2 + 1.46 NS
DDE 17.7 10.8
PBB 37.8 195.0
¢ 50 Age 58.1 6.10 57.4 6.27 +0.34 NS
Educ. 2.38 .83 2.86 0.91 -1.66 <0.05
BD 20.9 10.3 19.7 6.56 +0.40 NS
DS 34.0 10.5 30.5 7.81 + 1.09 NS
EF 27.7 7.7 24.9 8.15 + 1.06 NS
DDE 26.6 28.1
PBB 127.4 456.7
20.5 4.83 22.1 3.81 -0.88 NS
3.34 0.85 3.26 0.93 +0.20 NS
28.8 5.84 29.3 7.50 -1.58 NS
61.6 7.91 58.9 6.89 +0.85 NS
33.6 4.35 34.3 4.68 -0.34 NS
7.67 4.0
2.52 2.54
38.9 5.16 39.4 5.74 -0.30 NS
3.19 0.61 2.94 0.81 + 1.14 NS
26.9 9.22 24.8 9.68 +0.72 NS
57.0 11.26 56.6 12.46 +0.11 NS
32.8 4.54 33.9 3.08 -0.97 NS
13.8 8.04
3.26 6.78
54.7 10.5 54.0 2.55 +0.22 NS
2.97 1.06 3.13 0.78 -0.43 NS
23.9 9.19 26.9 7.48 -0.90 NS
50.0 11.02 48.18 10.51 +0.43 NS
31.7 4.34 31.5 5.13 +0.11 NS
17.9 5.11
2.93 1.99
" For age 0-29 yr, N = 16;30-49, N = 14; 50, N = 22.
" For age 0-29 yr,N = 23; 30-49, N = 46; 50, N = 15.
' For age 0-29 yr, N = 7; 30-49, N = 18; 50, N = 16.
"For age 0-29 yr, N = 19; 30-49, N = 27; ¢50, N = 11.
April 1978 203_ _ '_.,_ , _ I_L _ I _ L_L-_- E __ _- _ _
BD DS EF PBB BD DS EF PBB BD DS EF PBB MALES
00 WISCONSIN - WISCONSIN 60 WISCONSIN D FEMALES
0-29 30-49 50-OVER I5°1 50st50
40 40 40
BD DS EF BD DS EF BD DS EF
FIGURE 1. Results of three performance tests-Block Design (BD), Digit-Symbol (DS) and Embedded Figures (EF)-in males and
females in Michigan and Wisconsin for three age groups as shown. Asterisks indicate differences which are significant at the 1% and
5% levels respectively. Note that while in Wisconsin females scored better than males in one test (DS), in Michigan and particularly
in the 50 and over group, males scored worse than females in all tests. Serum PBB levels were significantly higher in males than
females in all age groups.
Table 6. Wisconsin vs. Michigan: matrices of intercorrelations between age, education, performance test scores
and serum DDE and PBB levels (males and females, all ages).
Sex Residence N r (0.05) r (0.01) Age Educ. BD DS EF DDE PBB
M Wisconsin 52 0.27 0.35 Age +1.00 -0.26 -0.41 -0.64 -0.51
Educ. + 1.00 +0.23 +0.53 +0.22
BD +1.00 +0.42 +0.56
DS +1.00 +0.51
EF +1.00
DDE +1.00
PBB +1.00
F Wisconsin 41 0.30 0.39 Age +1.00 -0.17 -0.40 -0.53 -0.29
Educ. +1.00 +0.12 +0.20 +0.23
BD +1.00 +0.24 +0.45
DS +1.00 +0.29
EF +1.00
DDE +1.00
PBB +1.00
M Michigan 84 0.20 0.26 Age +1.00 -0.22 -0.39 -0.57 -0.53 +0.42 +0.15
Educ. +1.00 +0.33 +0.44 +0.22 +0.05 +0.19
BD +1.00 +0.49 +0.63 -0.17 -0.09
DS +1.00 +0.49 -0.27 -0.07
EF +1.00 -0.36 -0.27
DDE +1.00 +0.55
PBB +1.00
F Michigan 57 0.27 0.35 Age +1.00 -0.13 -0.14 -0.31 -0.24 +1.61 +0.15
Educ. +1.00 +0.22 +0.38 +0.81 -0.12 -0.09
BD +1.00 +0.18 +0.38 -0.08 +0.04
DS +1.00 +0.18 -0.21 -0.16
EF +1.00 -0.16 -0.07
DDE +1.00 +0.46
PBB +1.00
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ress. Group size and critical values for the evalua-
tion of the significance of the correlation coeffi-
cients are shown at the bottom of each column.
With one exception (the correlation coefficient of
the BD test with serum PBB infemales), correlation
coefficients between performance test scores and
serum PBB levels were negative, suggesting that a
higher serum PBB level was associated with a lower
performance test score. The only statistically sig-
nificant correlation was that for EF test scores
among males. Two test scores (DS and EF) were
significantly and negatively correlated with serum
DDE levels. Tables 1 and 2 contain the complete
correlation matrices from which these data were de-
rived. Table 7 shows the correlation coefficients
between serum PBB and DDE levels and perfor-
mance test scores for Michigan males in three age
groups. Group size and critical values for the evalu-
ation of the significance of the correlation coeffi-
cients are shown at the bottom of each column.
In males, the correlation coefficient between
serum PBB levels and age showed a negative trend
in the three age groups (+ 0.27, - 0.20, and - 0.69);
no similar trend was observed in females (+ 0.19,
+ 0.37, and - 0.36). As previously shown, the mean
serum PBB levels for males were significantly
higher than for females. In males, the correlation
coefficient between serum DDE levels and age was
increasingly positive (+ 0.08, + 0.21, and + 0.57) in
the three consecutive age groups (statistically sig-
nificant for the older group). In females, serum
DDE level was significantly correlated with age in
the two younger groups.
The correlation coefficients between BD, DS and
EF test and serum PBB levels in males were pro-
gressively more negative as a function ofage group
but were not statistically significant. For the BD
test, the values were + 0.18, - 0.16, and - 0.32; for
the DS test, + 0.23, - 0.007, and - 0.41; andforthe
EF test, + 0.13, - 0.16, and - 0.57, respectively.
No similar trend was observed in the magnitude of
the correlation coefficients between test scores and
serum PBB levels in females as a function of age
group. A similar analysis for trends in the correla-
tion coefficients between serum DDE levels and
test scores revealed that these coefficients were
negative and in one case (EF) significant in males of
the oldest age group. No similar pattern was de-
tected in females.
The behavioral findings analyzed by means of
correlational techniques were convergent with
those obtained from assessment of population dif-
ferences (Fig. 1): severity ofcentral nervous system
dysfunction, as evaluated by means ofperformance
tests increased with age in the male group.
Neurological Symptoms
Figure 2 shows the percentage ofcases exhibiting
neurological symptoms in Michigan (white bars)
and Wisconsin (black bars) in a subsample of the
population also examined by means ofperformance
tests. The total numbers of people so examined in
Michigan and Wisconsin were 170 and 93, respec-
tively. While the number of reported symptoms
during the period 1972-1976 varied little in Wiscon-
sin, in Michigan there was a marked and significant
increase in these symptoms during the same period.
In this illustration the symptoms are ordered ac-
cording to the reported frequency of occurrence
during the last year (1976). It is interesting to note
that certain notable symptoms such as tiredness,
headaches, sleepiness, nervousness, dizziness,
blurred vision, muscle weakness and loss ofbalance
were reported less by Michigan residents for 1972
than by the Wisconsin group. Numerical data cor-
responding to this illustration are to be found in
Tables 8-10.
Table 7. Michigan: Correlation between DDE and PBB and performance test scores in males and females in three age groups.
Age 0-29 Age 3049 Age 2 50
Males Females Males Females Males Females
DDE PBB DDE PBB DDE PBB DDE PBB DDE PBB DDE PBB
Age +0.08 +0.27 +0.43 +0.19 +0.21 -0.20 +0.47 +0.37 +0.57 -0.69 -0.29 -0.36
BD +0.02 +0.18 +0.16 +0.05 +0.02 -0.06 +0.02 +0.03 -0.30 -0.32 -0.14 +0.41
DS -0.35 +0.23 -0.20 +0.05 -0.05 -0.007 -0.06 -0.23 -0.41 -0.41 -0.04 -0.09
EF -0.07 +0.13 -0.21 -0.14 +0.08 -0.06 -0.15 -0.16 -0.59 -0.57 +0.29 -0.15
DDE +0.32 - +0.34 -0.05 - +0.60 +0.94 - -0.21
N 23 19 46 27 15 11
r (0.05) 0.39 0.43 0.29 0.36 0.48 0.55
r (0.01) 0.50 0.55 0.37 0.47 0.60 0.68
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FIGURE 2. Proportion of cases exhibiting neurological symptoms in (O) Michigan and (-) Wisconsin in subsamples ofthe study
populations examined by means of performance tests. The totalnumberofexamined individuals in Michigan and Wiscon-
sin was 170and 93, respectively. While inthe Wisconsin group the number ofreported symptoms duringthe period 1972-1976
was stable, there was marked increase in these symptoms in the Michigan group in the same period.
Table 8. Time course of prevalence of neurological symptoms among Wisconsin residents (N = 92) as obtained by history.
1972 1973 1974 1975 1976
No. % No. % No. % No. % No. %
Tiredness 9 9.7 9 1.7 9 9.7 9 9.7 11 11.9
Headaches 7 7.6 7 7.6 7 7.6 8 8.7 8 8.7
Sleepiness 3 3.3 4 4.3 5 5.4 5 5.4 5 5.4
Nervousness 3 3.3 3 3.3 3 3.3 1 1.1 1 1.1
Depression I 1.1 1 1.1 1 1.1 1 1.1 2 2.2
Dizziness 3 3.3 3 3.3 4 4.3 4 4.3 5 5.4
Paresthesia 2 2.2 2 2.2 2 2.2 4 4.3 3 3.3
Blurred vision 3 3.3 3 3.3 4 4.3 3 3.3 4 4.3
Muscle weakness 5 5.4 4 4.3 3 3.3 3 3.3 3 3.3
Loss ofbalance 4 4.3 4 4.3 2 2.2 1 1.1 1 1.1
Sleeplessness 2 2.2 2 2.2 2 2.2 1 1.1 2 2.2
Perceptual change 0 0.0 0 0.0 1 1.1 1 1.1 2 2.2
Difficulty walking 2 2.2 3 3.3 1 1.1 0 0.0 0 0.0
Figure 3 illustrates the method used to calculate
the approximate time of onset of each symptom.
The proportions of persons with and without
symptoms in the Michigan and Wisconsin popula-
tions were compared for each year (1972-1976) by
using the chi-square test. The chi-square value was
plotted against time and the statistical significance
at the 0.05 and 0.01 level was indicated by the two
parallel lines. The points of intersect of these lines
with the curve resulting from successive chi-square
values indicate the time at which a symptom be-
came significantly more prevalent in the Michigan
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ITable 9. Time course of prevalence of neurological symptoms among Michigan residents (N = 166) as obtained by history.
1972 1973 1974 1975 1976
No. % No. % No. % No. % No. %
Tiredness 2 1.2 16 9.6 62 37 88 53 90 54
Headaches 10 6.0 17 10.2 41 25 53 32 64 39
Sleepiness 1 0.6 13 7.8 45 27 63 38 62 37
Nervousness 3 1.8 12 7.2 30 18 40 24 44 27
Depression 3 1.8 11 6.6 29 17 38 23 42 25
Dizziness 1 0.6 9 4.5 22 13 22 13 43 26
Paresthesia 3 1.8 7 4.2 22 13 26 16 36 22
Blurred vision 2 1.2 9 5.4 16 10 27 16 36 22
Muscle weakness 1 0.6 4 2.4 15 9 24 14 31 19
Loss of balance 2 1.2 7 4.2 20 12 29 17 30 18
Sleeplessness 1 0.6 4 2.4 15 9.0 25 15 30 18
Perceptual change 1 0.6 2 1.2 5 3.0 10 6.0 10 6.0
Difficulty walking 0 0.0 2 1.2 6 3.6 8 4.8 10 6.0
Table 10. Comparative percentages of prevalence of neurological symptoms among Wisconsin (W) and Michigan (M) residents
between 1972 and 1976 as obtained by history.
1972 1973 1974 1975 1976
W, % M, % W, % M, % W, % M, % W, % M, % W, % M, %
Tiredness 9.7 1.2 9.7 9.6 9.7 37 9.7 53 11.9 54
Headaches 7.6 6.0 7.6 10.2 7.6 25 8.7 32 8.7 39
Sleepiness 3.3 0.6 4.3 7.8 5.4 27 5.4 38 5.4 37
Nervousness 3.3 1.8 3.3 7.2 3.3 18 1.1 24 1.1 27
Depression 1.1 1.8 1.1 6.6 1.1 17 1.1 23 2.2 25
Dizziness 3.3 0.6 3.3 4.5 4.3 13 4.3 13 5.4 26
Paresthesia 2.2 1.8 2.2 4.2 2.2 13 4.3 16 3.3 22
Blurred vision 3.3 1.2 3.3 5.4 4.3 10 3.3 16 4.3 22
Muscle weakness 5.4 0.6 4.3 2.4 3.3 9 3.3 14 3.3 19
Loss of balance 4.3 1.2 4.3 4.2 2.2 12 1.1 17 1.1 18
Sleeplessness 2.2 0.6 2.2 2.4 2.2 9 1.1 15 2.2 18
Perceptual change 0.0 0.6 0.0 1.2 1.1 3 1.1 6 2.2 6
Difficulty walking 2.2 0.0 3.3 1.2 1.1 4 0.0 5 0.0 6
population. By this method it was possible to de-
termine the approximate time of onset of the vari-
ous symptoms reported by the examined persons at
the five and one percent level of significance.
The curves shown in Figure 4 represent the
growth of the magnitude of the chi-square for indi-
vidual symptoms as explained above. All symptoms
for which a significant difference between the
Michigan and Wisconsin examined population was
found in 1976 are represented in decreasing orderof
magnitude ofthe chi-square value. It was found that
neurological complaints represented the leading
symptoms. All seemed to be reaching a plateau in
1976 but none decreased significantly over the
years.
Figure 5 illustrates the time course of each
symptom as determined by the method described
above. A temporal sequence was reconstructed ac-
cording to their relative time ofonset(the number in
the scale indicates months as relative units). No at-
tempt was made to determine the precise time of
onset of the symptom although the relative time of
onset could be ascertained. The dashed and solid
lines indicate areas where the criterion for signifi-
cance of 5 and 1%, respectively, was met. All the
symptoms without exception listed in Table 3 were
considered forthis analysis, and only those showing
significant differences when compared to the Wis-
consin population are shown.
In the Michigan population, the onset of
neurological symptoms preceded all others. The
frequency ofsome ofthe symptoms, such as nausea
and dizziness, increased slowly over the months
whereas others, such as depression, nervousness,
paresthesia, tiredness, sleepiness and headaches
showed a more rapid increase in prevalence. In-
terestingly, "'motor involvement" such as loss of
balance, muscle weakness, difficulty in walking,
and blurred vision occurred relatively later in time
or showed a slower rate of increase. Finally, the
April 1978 207FIGURE 3. Illustration ofthe method used to calculate the time of
onset ofsymptoms in the Michigan population. Proportion of
persons with and without symptoms in the Michigan and
Wisconsin population were compared for each year (1972-
1976) by usingthe chi-square test. The value ofthe chi-square
was plotted against time and the statistical significance at the
0.05 and 0.01 levels is indicated by the two parallel horizontal
lines. The points of intersect of these lines with the curve
resulting from successive chi-square values indicate the time
at which a symptom became significantly more prevalent in
the Michigan population. By this method is was possible to
determine the approximate time of onset of the various
symptoms reported by the group at the 5% and 1% levels of
significance.
prevalence of symptoms such as increased perspi-
ration, slower healing ofcuts, and nail discoloration
progressed slowly during 3-7 months. Some of
these symptoms, such as increased perspiration,
swelling of joints, and difficulty in walking were
never reported significantly higher than at the 5%
level, compared to the Wisconsin population.
Tables 11 and 12 are summaries ofdata. Table 12
lists significant symptoms as observed in
November of 1976. The left column indicates pro-
portion of cases in Michigan listed in decreasing
order of significance. The column on the right is a
list of significant symptoms as detected by the chi-
square test, also listed in decreasing order ofsignifi-
cance.
Table 12 contains the evolution of symptoms as
reconstructed from the special questionnaire and
the method described above: the higher the position
in the list, the earlier its occurrence. It is shown that
the order in which symptoms have established
themselves varies according to whether a less con-
servative criterion (5%) or a more conservative
criterion (1%) was taken. However, in both cases
neurological symptoms were the earliest manifesta-
tion of abnormalities in the Michigan population.
Discussion
Preliminary analysis of data reported here indi-
cates that a significant constellation of neurological
symptoms occurred among dairy farmers during the
period 1972-1976, when patterns for a non-PBB-
exposed dairy farm population are taken as a refer-
ence. Simple statistical procedures demonstrate that
neurological symptoms were also likely to be the ear-
liest manifestations of abnormalities among the
Michigan dairy farmers. Performance test results
suggest that in older males, higher serum PBB levels
were more likely to be associated with dysfunction.
Serum PBB levels are significantly higher in
males than in females in all age groups and, in gen-
eral, performance test scores are lower in males
than in females. However, since in some tests, such
as the DS test, women scored better than males in
the reference population also, interpretation ofthese
results should be made with caution. However, after
consideringthesefactors, there isadistinctive group
ofmales (50 and over) which performed significantly
less well than the control population.
Analysis of correlations between symptoms and
serum PBB levels in males and females of various
age groups and between performance tests and
neurological symptoms is still in progress. PBB
levels in depot fat biopsies are expected to be avail-
able and will add anotherdimension to this analysis.
It is possible that fat PBB levels may be even more
closely related to neurobehavioral symptoms and
behavioral test scores.
As determined at one specific point in time
(November 1976), neurological symptoms that are
significantly more prevalent in Michigan seemed to
have reached a plateau.
We attempted to eliminate descriptions of anec-
dotal type, although the descriptions-such as
numerous reports of marked memory difficulties-
illuminate the symptomatology that we describe
here only briefly. In this report, our analysis was
restricted to those data which could be documented
as objectively as possible.
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FIGURE 4. Changes in chi-square values over time for individuals symptoms according to the method described in Fig. 3. All symptoms
in which there was a significant difference between the Michigan and Wisconsin populations in 1976 are represented. As can be
seen, neurological symptoms led. All seemed to reach a plateau but none decreased over the years so far studied.
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FIGURE 5. Time ofonset ofall significant symptoms in the Michi-
gan population. The time of onset was determined by means
of the method described in Fig. 3. The upper scale indicates
months as a relative unit. Although no attempt was made to
determine the precise time of onset of the symptoms, their
onset could be ascertained with respect to each other. Signifi-
cance at the 5% and 1% level are indicated by white and
dashed bars, respectively, and the arrangement is made ac-
cording to the 1% level of significance.
Table 11. Symptoms observed among Michigan dairy farmers
in 1976.
Proportion of cases Significance of
(1976, Michigan) difference between groups
Tiredness Tiredness
Headaches Nervousness
Sleepiness Sleepiness
Drier skin Headaches
Nervousness Paresthesia
Paresthesia Dizziness
Perspiration Depression
Dizziness Vomiting
Depression Nail discoloration
Blurred vision Loss of balance
Muscle weakness Blurred vision
Loss of balance Drier skin
Healing cuts Muscle weakness
Vomiting Healing cuts
Nail discoloration Difficulty walking
Difficulty walking Perspiration
Swelling ofjoints Swelling ofjoints
Table 12. Sequence of appearance of symptoms among Michigan
dairy farmers.
5% criterion 1% criterion
Depression Depression
(Nausea) vomiting Nervousness
Nervousness Tiredness
Paresthesia Paresthesia
Tiredness Sleepiness
Dizziness Perspiration
Sleepiness Headaches
Headaches Dizziness
Perspiration Vomiting
Drier skin Loss of balance
Loss ofbalance Difficulty walking
Healing cuts Drier skin
Nail discoloration Blurred vision
Muscle weakness Muscle weakness
Difficulty walking Nail discoloration
Blurred vision Healing cuts
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